Cargando…
Restoration of MiR-34a Expression by 5-Azacytidine Augments Alimta -Induced Cell Death in Non-Small Lung Cancer Cells by Downregulation of HMG B1, A2 and Bcl-2 Pathway
OBJECTIVE: Alimta (Pemetrexed) as an antifolate drug has been approved for the treatment of lung cancer. The aim of the present study was to investigate the combination effect of 5-Azacytidine (5-aza) and Alimta on the miR-34a and its target genes expression and induction of apoptotic cell death in...
Autores principales: | Amiri, Somayeh, Rabbani-Chadegani, Azra, Davoodi, Jamshid, Fakhrabadi, Hoda Gol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royan Institute
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665979/ https://www.ncbi.nlm.nih.gov/pubmed/34939761 http://dx.doi.org/10.22074/cellj.2021.7332. |
Ejemplares similares
-
Studies on the binding affinity of anticancer drug mitoxantrone to chromatin, DNA and histone proteins
por: Hajihassan, Zahra, et al.
Publicado: (2009) -
The effect of mitoxantrone as an anticancer drug on hepatocytes nuclei and chromatin: Selective release of histone proteins
por: Hajihassan, Zahra, et al.
Publicado: (2011) -
Evaluation of Apoptosis in Multipotent Hematopoietic Cells of Bone Marrow by Anthracycline Antibiotics
por: Aramvash, Asieh, et al.
Publicado: (2017) -
BCL-2 family proteins as 5-Azacytidine-sensitizing targets and determinants of response in myeloid malignancies
por: Bogenberger, J M, et al.
Publicado: (2014) -
Development of an Oral Form of Azacytidine: 2′3′5′Triacetyl-5-Azacytidine
por: Ziemba, Amy, et al.
Publicado: (2011)